Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib in Recurrent or Metastatic Advanced Thymic Epithelial Tumors
NCT03219554Phase 2Unknown
- Sponsor
- Samsung Medical Center
- Start
- Aug 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in thymic epithelial tumor (TET), sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
palbociclib
03
Conditions
thymic epithelial tumor (TET)
Beyond the preview
Go deeper on NCT03219554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03219554.